Nana Peng, Mary Yue Wang, Sherlot Juan Song, Jimmy Che-To Lai, Vicki Wing-Ki Hui, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Mamatha Bhat, Terry Cheuk-Fung Yip
Clin Mol Hepatol 2026;32(4):e2026.0258. Published online July 23, 2026
Artificial intelligence (AI), particularly foundation and generative models, is reshaping the practice of hepatology through enhanced knowledge synthesis, quantitative and reproducible analysis of multimodal data, and personalized clinical decision support. This narrative review examines the transition from task-specific discrimination AI to large language models (LLMs), multimodal foundation models, and agentic AI. We synthesize evidence from original and validation studies, clinical evaluations, and benchmark studies, as well as expert reviews and regulatory frameworks across metabolic dysfunction-associated steatotic liver disease, chronic hepatitis B, cirrhosis and portal hypertension, hepatocellular carcinoma, and liver transplantation. LLMs can convert free-text notes into structured data, summarize longitudinal electronic health records, support patient education, and retrieve guideline-based information. Retrieval-augmented generation and agentic AI may improve traceability and workflow support, but current evidence is largely retrospective or proof-of-concept. In digital pathology and imaging, discriminative AI has enabled more quantitative and reproducible histologic scoring and biomarker analysis. Pathology and multimodal foundation models offer transferable representations, report generation, and cross-modal reasoning, but hepatology-specific validation remains limited. Key risks include hallucination, automation bias, domain shift across centers and devices, and inequities due to under-representation of patient subgroups. We outline the future directions for safe AI model deployment based on multimodal foundation models, prospective and federated evaluation, lifecycle governance, and continuous monitoring for performance, calibration, and equity. Most generative AI applications in hepatology remain at the proof-of-concept stage, and rigorous prospective validation with human-in-the-loop oversight is required before clinical integration.
Citations
Citations to this article as recorded by
Clinical Application of Artificial Intelligence in the Management of Chronic Hepatitis B Jimmy Che‐To Lai, Xiaoqing Guo, Xinyan Zong, Nana Peng, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Pong‐Chi Yuen, Grace Lai‐Hung Wong Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver biochemical markers. Liver histology keeps its role as the standard tool, yet it is well-known for substantial sampling, intraobserver, and interobserver variability. Serum proinflammatory cytokines and apoptotic markers, namely cytokeratin-18, are well-studied with reasonable accuracy, whereas serum metabolomics and lipidomics have been adopted in some commercially available diagnostic models. Ultrasound and computed tomography imaging techniques are attractive due to their wide availability; yet their accuracies may not be comparable with magnetic resonance imaging-based tools. Machine learning and deep learning models, be they supervised or unsupervised learning, are promising tools to identify various subtypes of NAFLD, including those with dominating liver inflammation, contributing to sustainable care pathways for NAFLD.
Citations
Citations to this article as recorded by
Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology Ruotong Li, Kunyu Zou, Qihang Ma, Yaping Liu, Xiaohui Wang, Wenbin Huang, Shegan Gao, Xueying Yang Frontiers in Oncology.2026;[Epub] CrossRef
Diagnostic Performance of Shear-Wave Dispersion Slope for Biopsy-Proven Hepatic Inflammation in MASLD: A Systematic Review and HSROC Meta-Analysis Caixin Qiu, Meina Cai, Lulu Lyu, Peng Xu Ultrasound in Medicine & Biology.2026; 52(5): 916. CrossRef
ROS-Responsive Prodrug Containing Dihydroartemisinin and Cinnamaldehyde for the Potential Treatment of Nonalcoholic Steatohepatitis Ru Hao, Yi Sun, Changyuan Wang, Yang Wang, Lei Li, Huijun Sun, Lixue Chen ACS Applied Materials & Interfaces.2026; 18(9): 13384. CrossRef
Potential Drug Targets and Causal Plasma Proteins Related to Preeclampsia Identified by Mendelian Randomization Wei Zhou, Ting Huang, Lei Li, Yanli Shen, Zhe Ji, Meng Yan Women's Health Reports.2026;[Epub] CrossRef
Clinical Integration of Novel Non‐Invasive Biomarkers in Hepatology: Bridging Statistical Promise and Bedside Utility F. N. U. Mehrish, Talha Khan, Mujtaba Moazzam Journal of Gastroenterology and Hepatology.2026; 41(6): 1915. CrossRef
Chronic exposure to environmentally relevant Bisphenol F induces hepatic injury and inflammation in Zebrafish Yuehong Shen, Dingyu Zhou, Tong Wei, Tuantuan Lei, Yuanhui Zhu, Mengyuan Liang, Junjie Sun, Peng Wang, Guixiang Ji, Jie Gu, Han Gao, Wenzhu Wu Aquatic Toxicology.2026; 296: 107825. CrossRef
MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways Shengfang Liu, Qingjuan Zhang, Lijing Wang, Qin Tang, Bingtao Hu Frontiers in Medicine.2026;[Epub] CrossRef
Effects and Mechanisms of Stevioside on Metabolic Dysfunction‐Associated Steatotic Liver Disease Kangjun Li, Changfa Zhang, Lili Kang, Yunping Mu, Zemin Li, Jingyi Zhang, Guowei Li Food Science & Nutrition.2026;[Epub] CrossRef
Using machine learning to identify the most important predictors of fatty liver index in healthy young Taiwanese men Yu-Chen Tseng, Ta-Wei Chu, Chiu-Sung Ko, Dee Pei, Kai-Jo Chiang Scientific Reports.2026;[Epub] CrossRef
Imaging-based fibrosis assessment and risk stratification in MASLD Shunqin Jin, Tao Zhou, Dachuan Jin, Jiahao Xie, Guoping Sheng, Hongzhi Li, Guangming Li, Chuan Qin, Peng Gao Frontiers in Medicine.2026;[Epub] CrossRef
Mediation of the association between physical activity and metabolic dysfunction-associated fatty liver disease in children and adolescents by inflammatory markers: an analysis of 2017‒2020 NHANES data Chunyang Zhang, Xiaonan Li Clinics.2026; 81: 101056. CrossRef
Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions Lijia Yin, Huikuan Chu, Ling Yang Portal Hypertension & Cirrhosis.2026;[Epub] CrossRef
Automated Machine Learning Model for Non-Alcoholic Fatty Liver Disease Prediction and External Cohort Validation Mingjie Li, Yadong Li, Lihui Chen, Han Chen, Lishengdan Chen, Wenyue Liu, Gang Xu, Shuying Chen Journal of Visualized Experiments.2026;[Epub] CrossRef
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018 Ming-yu He, Xin-jie Du, Yi-ming Liu BMC Gastroenterology.2025;[Epub] CrossRef
Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease Yunfei Wu, Yan Han, Liming Zheng, Longgen Liu, Wenjian Li, Fan Zhang BMC Gastroenterology.2025;[Epub] CrossRef
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta‐Analysis Jinwen Chen, Jian Hu, Jialin Zhuang, Zhong Li, Se Peng, Xiaoting Huang, Jialing Zhuang Journal of Clinical Laboratory Analysis.2025;[Epub] CrossRef
Obesity: pathophysiology and therapeutic interventions Yue Kong, Haokun Yang, Rong Nie, Xuxiang Zhang, Fan Zuo, Hongtao Zhang, Xin Nian Molecular Biomedicine.2025;[Epub] CrossRef
The advanced lung cancer inflammation index has an L-shaped association with prognosis in American adults with metabolic dysfunction-associated fatty liver disease: a cohort study Yuexia Lu, Shuaipeng Yuan, Huazhao Xu, Jiqi Ouyang, Jinsheng Dong, Xin Jiang, Xiao Shao, Runshun Zhang Frontiers in Nutrition.2025;[Epub] CrossRef
Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis Jing-Wen Cai, Wei-Long Wang, Dong-Ling Lin, Shu-Feng Ren, Qian-Qian Jia, Xiao-Xuan He, Xue-Xia Yang, Wen Cai, Hui Hou Journal of Multidisciplinary Healthcare.2025; Volume 18: 4243. CrossRef
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration Evelien Van Dijck, Steven Van Laere, Emilie Logie, Steven Timmermans, Erik Fransen, Joe Ibrahim, Timothy J. Kendall, Jonathan A. Fallowfield, Ligia M. Mateiu, Claude Libert, Guy Van Camp, An Verrijken, Luc Van Gaal, Sven Francque, Wim Van Hul, Wim Vanden Clinical Epigenetics.2025;[Epub] CrossRef
Quantification of 18F-FDG Delivery Rate for Liver Inflammation Using Shortened Dynamic PET Imaging Protocols Xiaoyu Duan, Souvik Sarkar, Victoria Lyo, Sean Romeo, Benjamin A. Spencer, Karen E. Matsukuma, Valentina Medici, Michael T. Corwin, Ramsey D. Badawi, Guobao Wang Journal of Nuclear Medicine.2025; 66(11): 1834. CrossRef
ChatGPT improves usability, effectiveness, scalability, interpretability and accessibility, in early diagnosis of metabolic dysfunction-associated fatty liver disease Xiaoying Zhou, Zhipeng Gao, Han Ma, Jiahui Hu, Chengfu Xu, Zhe Shen, Miaomiao Tan, Chaohui Yu BMC Gastroenterology.2025;[Epub] CrossRef
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan I Alimentary Pharmacology & Therapeutics.2024; 59(1): 80. CrossRef
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon European Journal of Gastroenterology & Hepatology.2024; 36(4): 445. CrossRef
Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, Adrian Dobrinescu, Vlad Pădureanu, Venera Cristina Dinescu, Mircea-Cătălin Forțofoiu Metabolites.2024; 14(4): 198. CrossRef
Editorial: Inflammation and chronic disease Frank A. Orlando, Arch G. Mainous Frontiers in Medicine.2024;[Epub] CrossRef
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis Shaofang Chen, Danping Zhuang, Qingyun Jia, Bing Guo, Genwen Hu Biomaterials Research.2024;[Epub] CrossRef
Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis Xin Zhang, Jiangguo Li, Li Jiang, Yuexia Deng, Licheng Wei, Xing Li Clinical and Experimental Medicine.2024;[Epub] CrossRef
The Metabolomic Footprint of Liver Fibrosis Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle Cells.2024; 13(16): 1333. CrossRef
Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model Marwa Matboli, Ibrahim Abdelbaky, Abdelrahman Khaled, Radwa Khaled, Shaimaa Hamady, Laila M. Farid, Mariam B. Abouelkhair, Noha E. El-Attar, Mohamed Farag Fathallah, Manal S. Abd EL Hamid, Gena M. Elmakromy, Marwa Ali Lipids in Health and Disease.2024;[Epub] CrossRef
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH Anja Schmidt-Christensen, Gustaw Eriksson, William M. Laprade, Behnaz Pirzamanbein, Maria Hörnberg, Kajsa Linde, Julia Nilsson, Mark Skarsfeldt, Diana J. Leeming, Rajmund Mokso, Mariana Verezhak, Anders Dahl, Vedrana Dahl, Kristina Önnerhag, Massoud Rezae Scientific Reports.2024;[Epub] CrossRef
Polygala japonica Houtt.: A comprehensive review on its botany, traditional uses, phytochemistry, pharmacology, and pharmacokinetics Hai-Peng Tang, En-Lin Zhu, Qian-Xiang Bai, Shuang Wang, Zhi-Bin Wang, Meng Wang, Hai-Xue Kuang Fitoterapia.2024; 179: 106233. CrossRef
Chondroitin Sulfate from Halaelurus burgeri Skin Inhibits Hepatic Endoplasmic Reticulum Stress and Inflammation, and Regulates Gut Microbiota Zhaocai Ren, Shang Gao, Shiwei Hu, Sichun Chen, Wei Jiang, Yaming Ge Molecular Nutrition & Food Research.2024;[Epub] CrossRef
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Miwa Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, Michihiro Iwaki, Ken Nishino, Wenli Zhao, Yuya Seko, Masato Yoneda, Yoshihito Kubotsu, Hideki Fujii, Yoshio Sumida, Hirofumi Kawamoto, Yoshito Itoh, Atsushi Nakajima, Takeshi Okanoue, Takumi Kawaguchi, Gastro Hep Advances.2024; 3(8): 1120. CrossRef
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle International Journal of Molecular Sciences.2024; 25(23): 12809. CrossRef
MASLD: predictive value for liver-related events and extra-hepatic complications Mohamad Jamalinia, Amedeo Lonardo Expert Review of Gastroenterology & Hepatology.2024; 18(11): 685. CrossRef
Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification Hwi Young Kim, Da Jung Kim, Hye Ah Lee, Joo-Youn Cho, Won Kim Metabolites.2023; 13(3): 444. CrossRef
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean‐Francois Gautier, Angélique Brzustowski, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla Alimentary Pharmacology & Therapeutics.2023; 58(9): 888. CrossRef
Molecular tests are necessary to stratify cancer patients for targeted therapy. However, high cost and technical barriers limit the application of these tests, hindering optimal treatment. Recently, deep learning (DL) has been applied to predict molecular test results from digitized images of tissue slides. Furthermore, treatment response and prognosis can be predicted from tissue slides using DL. In this review, we summarized DL-based studies regarding the prediction of genetic mutation, microsatellite instability, tumor mutational burden, molecular subtypes, gene expression, treatment response, and prognosis directly from hematoxylin- and eosin-stained tissue slides. Although performance needs to be improved, these studies clearly demonstrated the feasibility of DL-based prediction of key molecular features in cancer tissues. With the accumulation of data and technical advances, the performance of the DL system could be improved in the near future. Therefore, we expect that DL could provide cost- and time-effective alternative tools for patient stratification in the era of precision oncology.
Citations
Citations to this article as recorded by
Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell Yiyao Yang, Yuxin Guo, Zhaoliang Wang, Yifan Weng, Tingting Hao, Qingqing Zhang, Shuihua Wang, Zhiyong Guo Biosensors and Bioelectronics.2026; 291: 118051. CrossRef
Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases Huiting Che, Yidan Gao, Yonghu Xu, Hui Xu, Roland Eils, Mei Tian Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
What if Every Patient’s Immune System Could be Guided by the World’s Most Powerful Computers to Fight Cancer? The UK Cancer Vaccines AI and Supercompute Project Michael E. Bryan, Joseph Conway, Gareth Bloomfield, Aska Matsunaga, David Narganes-Carlon, Ian Lowenhoff, Nick K. Davis, Justin K.H. Liu, Qamar Ghafoor, Michael Tilby, Michael Rowe, Isabella Watts, Sam Khan, Rene Roux, Kristen Dahlgren, Matt Hancock, Elis EMJ Innovation.2026;[Epub] CrossRef
Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren Exploration of Digestive Diseases.2026;[Epub] CrossRef
PH2ST: Prompt-guided hypergraph learning for spatial transcriptomics prediction in whole slide images Yi Niu, Jiashuai Liu, Yingkang Zhan, Jiangbo Shi, Di Zhang, Marika Reinius, Ines Machado, Mireia Crispin-Ortuzar, Jialun Wu, Chen Li, Zeyu Gao Medical Image Analysis.2026; 110: 104008. CrossRef
Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features Xin Pan, Linwen Lv, Jiayi Wang, Haojun Liang, Jiaxin Wan, Junhui Zhang, Ruyu Yan, Juan Li, Ya-nan Chang, Xue Bai, Lu Zhang, Gengmei Xing, Kui Chen ACS Nano.2026; 20(14): 11409. CrossRef
Advancements in artificial intelligence for cancer diagnosis and prognosis prediction: current applications and emerging opportunities Qingmiao Shi, Na Lou, Chen Xue Frontiers in Cell and Developmental Biology.2026;[Epub] CrossRef
Explainable deep learning approaches and clinical insights for cancer biomarker identification Kshitij Srivastava, Ruby Srivastava Frontiers in Oncology.2026;[Epub] CrossRef
Comparative Analysis of Deep Learning Approaches for Histopathology-Based Survival Prediction in Hepatocellular Carcinoma Sung Hak Lee, Kwangil Yim, Hyun-Jong Jang Cancers.2026; 18(10): 1534. CrossRef
Deep Learning-Based Diagnosis of Epithelial Ovarian Cancer from Whole-Slide Histopathology Images Jihyun Chun, Haeyoun Kang, Heewon Chung, Jae-Myung Jang, Jangwon Seo, Taegyu Kim, Woohyun Lee, Cheolhong Park, Mingi Hong, Han-Mac Brian Kim, Messi H. J. Lee, Kyongseok Jang, Chan Kwon Jung, Sang Wun Kim, Ahwon Lee Diagnostics.2026; 16(10): 1470. CrossRef
Profiling of extracellular vesicles from primary hepatocytes, organoids, and mash patients identifies cell injury-specific signatures Aleksandra Leszczynska, Benedikt Kaufmann, Hana Sung, Christian Stoess, Agustina Reca, Andrea Kim, Yeon-Kyung Choi, Chelsea Tran, Sung-Eun Kim, Davide Povero, Bruce Wolfe, Trevor Crafts, Akiko Eguchi, Ariel E. Feldstein Scientific Reports.2026;[Epub] CrossRef
Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers Hyun-Jong Jang, Kwangil Yim, Sung Hak Lee International Journal of Molecular Sciences.2026; 27(15): 6969. CrossRef
Cross‐Species Generalization and Comparative Performance Analysis of Deep Neural Network Architectures in Histological Image Classification Kaan Celen, Fatih Oltulu, Buse Caglar, Aylin Buhur, Burak Kilicarslan, Burhan Berk Çolak, Altug Yavasoglu Microscopy Research and Technique.2026;[Epub] CrossRef
Predicting Tumor Mutational Burden in Prostate Cancer Using Deep Learning on Histopathological Images Tekin Ahmet Serel, Onur Ertunç, Merve Meryem Kıran, Esra Şengül, Zeynep Ruken Hakkoymaz, Eda Uysal Aydın OBM Genetics.2026; 010(03): 1. CrossRef
Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data Leonid Mill, Oliver Aust, Jochen A. Ackermann, Philipp Burger, Monica Pascual, Katrin Palumbo-Zerr, Gerhard Krönke, Stefan Uderhardt, Georg Schett, Christoph S. Clemen, Christian Holtzhausen, Samir Jabari, Rolf Schröder, Andreas Maier, Anika Grüneboom Communications Medicine.2025;[Epub] CrossRef
Deep Learning–Powered Whole Slide Image Analysis in Cancer Pathology Chengrun Dang, Zhuang Qi, Tao Xu, Mingkai Gu, Jiajia Chen, Jie Wu, Yuxin Lin, Xin Qi Laboratory Investigation.2025; 105(7): 104186. CrossRef
Recent advances and challenges in colorectal cancer: From molecular research to treatment Gao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Shang Wang, Jing Xu World Journal of Gastroenterology.2025;[Epub] CrossRef
Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review Samanta Ortuño-Miquel, Reyes Roca, Cristina Alenda, Francisco Aranda, Natividad Martínez-Banaclocha, Sandra Amador, David Gil Cancers.2025; 17(22): 3619. CrossRef
AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology Hyun-Jong Jang, Sung Hak Lee International Journal of Molecular Sciences.2025; 27(1): 379. CrossRef
Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy Abu Bakr Azam, Felicia Wee, Juha P. Väyrynen, Willa Wen-You Yim, Yue Zhen Xue, Bok Leong Chua, Jeffrey Chun Tatt Lim, Aditya Chidambaram Somasundaram, Daniel Shao Weng Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan Frontiers in Immunology.2024;[Epub] CrossRef
Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma” Su Bin Lim, Hyo Jung Cho Clinical and Molecular Hepatology.2024; 30(4): 1009. CrossRef
Integrating transcriptomic data and digital pathology for NRG-based prediction of prognosis and therapy response in gastric cancer Qiuyan Sun, Tan Li, Zheng Wei, Zhiyi Ye, Xu Zhao, Jingjing Jing Annals of Medicine.2024;[Epub] CrossRef
Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study Xin Wang, Jing Xu, Zhenya Jia, Guoping Sun Medicine.2024; 103(50): e40889. CrossRef
Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang International Journal of Cancer.2023; 152(2): 298. CrossRef
A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh International Journal of Molecular Sciences.2023; 24(2): 1681. CrossRef
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła Biomedicines.2023; 11(3): 842. CrossRef
Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An Therapeutic Advances in Medical Oncology.2023;[Epub] CrossRef
High-content microscopy reveals a morphological signature of bortezomib resistance Megan E Kelley, Adi Y Berman, David R Stirling, Beth A Cimini, Yu Han, Shantanu Singh, Anne E Carpenter, Tarun M Kapoor, Gregory P Way eLife.2023;[Epub] CrossRef
Deep Learning-Based Classification of Uterine Cervical and Endometrial Cancer Subtypes from Whole-Slide Histopathology Images JaeYen Song, Soyoung Im, Sung Hak Lee, Hyun-Jong Jang Diagnostics.2022; 12(11): 2623. CrossRef
Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review Heather D. Couture Journal of Personalized Medicine.2022; 12(12): 2022. CrossRef